130 related articles for article (PubMed ID: 6142906)
1. Pharmacokinetic noninteraction of triazolam and ethanol.
Ochs HR; Greenblatt DJ; Arendt RM; Hübbel W; Shader RI
J Clin Psychopharmacol; 1984 Apr; 4(2):106-7. PubMed ID: 6142906
[TBL] [Abstract][Full Text] [Related]
2. Interaction of cimetidine with the triazolobenzodiazepines alprazolam and triazolam.
Abernethy DR; Greenblatt DJ; Divoll M; Moschitto LJ; Harmatz JS; Shader RI
Psychopharmacology (Berl); 1983; 80(3):275-8. PubMed ID: 6137021
[TBL] [Abstract][Full Text] [Related]
3. Triazolam and ethanol interaction: kinetic and dynamic consequences.
Dorian P; Sellers EM; Kaplan HL; Hamilton C; Greenblatt DJ; Abernethy D
Clin Pharmacol Ther; 1985 May; 37(5):558-62. PubMed ID: 2859136
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of triazolam in geriatric patients.
Dehlin O; Björnson G; Börjesson L; Abrahamsson L; Smith RB
Eur J Clin Pharmacol; 1983; 25(1):91-4. PubMed ID: 6137388
[TBL] [Abstract][Full Text] [Related]
5. Mibefradil but not isradipine substantially elevates the plasma concentrations of the CYP3A4 substrate triazolam.
Backman JT; Wang JS; Wen X; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 1999 Oct; 66(4):401-7. PubMed ID: 10546924
[TBL] [Abstract][Full Text] [Related]
6. Differential impairment of triazolam and zolpidem clearance by ritonavir.
Greenblatt DJ; von Moltke LL; Harmatz JS; Durol AL; Daily JP; Graf JA; Mertzanis P; Hoffman JL; Shader RI
J Acquir Immune Defic Syndr; 2000 Jun; 24(2):129-36. PubMed ID: 10935688
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of isoniazid on triazolam oxidation and oxazepam conjugation.
Ochs HR; Greenblatt DJ; Knüchel M
Br J Clin Pharmacol; 1983 Dec; 16(6):743-6. PubMed ID: 6140941
[TBL] [Abstract][Full Text] [Related]
8. Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity.
Greenblatt DJ; Divoll M; Abernethy DR; Moschitto LJ; Smith RB; Shader RI
Br J Clin Pharmacol; 1983 Mar; 15(3):303-9. PubMed ID: 6133545
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic consequences of long term coadministration of cimetidine and triazolobenzodiazepines, alprazolam and triazolam, in healthy subjects.
Pourbaix S; Desager JP; Hulhoven R; Smith RB; Harvengt C
Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):447-51. PubMed ID: 2864320
[TBL] [Abstract][Full Text] [Related]
10. Relationship between single oral dose pharmacokinetics of alprazolam and triazolam.
Otani K; Yasui N; Furukori H; Kaneko S; Tasaki H; Ohkubo T; Nagasaki T; Sugawara K; Hayashi K
Int Clin Psychopharmacol; 1997 May; 12(3):153-7. PubMed ID: 9248872
[TBL] [Abstract][Full Text] [Related]
11. Assay of triazolam in plasma by capillary gas chromatography.
Jochemsen R; Breimer DD
J Chromatogr; 1981 May; 223(2):438-44. PubMed ID: 6114106
[No Abstract] [Full Text] [Related]
12. Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics.
Stoehr GP; Kroboth PD; Juhl RP; Wender DB; Phillips JP; Smith RB
Clin Pharmacol Ther; 1984 Nov; 36(5):683-90. PubMed ID: 6149030
[TBL] [Abstract][Full Text] [Related]
13. Effect of grapefruit juice dose on grapefruit juice-triazolam interaction: repeated consumption prolongs triazolam half-life.
Lilja JJ; Kivistö KT; Backman JT; Neuvonen PJ
Eur J Clin Pharmacol; 2000 Aug; 56(5):411-5. PubMed ID: 11009051
[TBL] [Abstract][Full Text] [Related]
14. Enhanced bioavailability of triazolam following sublingual versus oral administration.
Scavone JM; Greenblatt DJ; Friedman H; Shader RI
J Clin Pharmacol; 1986 Mar; 26(3):208-10. PubMed ID: 3958225
[TBL] [Abstract][Full Text] [Related]
15. Electron-capture gas chromatographic analysis of the triazolobenzodiazepines alprazolam and triazolam.
Greenblatt DJ; Divoll M; Moschitto LJ; Shader RI
J Chromatogr; 1981 Sep; 225(1):202-7. PubMed ID: 6117563
[No Abstract] [Full Text] [Related]
16. Pharmacokinetics and clinical effects of sublingual triazolam in pediatric dental patients.
Tweedy CM; Milgrom P; Kharasch ED; Kaakko T; Spieker M; Coldwell SE
J Clin Psychopharmacol; 2001 Jun; 21(3):268-72. PubMed ID: 11386489
[TBL] [Abstract][Full Text] [Related]
17. Population study of triazolam pharmacokinetics.
Friedman H; Greenblatt DJ; Burstein ES; Harmatz JS; Shader RI
Br J Clin Pharmacol; 1986 Dec; 22(6):639-42. PubMed ID: 3567010
[TBL] [Abstract][Full Text] [Related]
18. Triazolam kinetics: interaction with cimetidine, propranolol, and the combination.
Friedman H; Greenblatt DJ; Burstein ES; Scavone JM; Harmatz JS; Shader RI
J Clin Pharmacol; 1988 Mar; 28(3):228-33. PubMed ID: 3360971
[TBL] [Abstract][Full Text] [Related]
19. Effect of methylprednisolone on CYP3A4-mediated drug metabolism in vivo.
Villikka K; Varis T; Backman JT; Neuvonen PJ; Kivistö KT
Eur J Clin Pharmacol; 2001 Sep; 57(6-7):457-60. PubMed ID: 11699609
[TBL] [Abstract][Full Text] [Related]
20. Effects of dosing interval on the pharmacokinetic and pharmacodynamic interactions between the oral adsorbent AST-120 and triazolam in humans.
Kotegawa T; Tsutsumi K; Morita H; Imai H; Morita M; Yoshizato T; Ohyama T; Uchida S; Watanabe H; Namiki N; Ohashi K
Eur J Clin Pharmacol; 2012 Dec; 68(12):1605-10. PubMed ID: 22644342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
